Description

Semaglutide is a GLP 1 receptor agonist widely researched in metabolic and endocrine studies. Research has examined its interaction with GLP 1 receptor signalling and biological pathways associated with glucose regulation, appetite related mechanisms, and energy metabolism. Its established research profile has made Semaglutide an important compound for investigating metabolic signalling and related physiological processes. Researchers continue to study GLP 1 pathways across different experimental models to better understand their role in metabolic biology. This formulation contains 10mg across 10 vials and is supplied for controlled laboratory research into GLP 1 receptor activity, metabolic signalling, glucose regulation, and related biological mechanisms.